世界の足場技術市場2021-2028:種類別、用途別(幹細胞、再生医療、創薬)、疾患別(癌、歯科、神経)、最終用途別

◆英語タイトル:Scaffold Technology Market Size, Share & Trends Analysis Report By Type, By Application (Stem Cell, Regenerative Medicine, Drug Discovery), By Disease Type (Cancer, Dental, Neurology), By End-use, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MY029
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年5月11日
◆ページ数:190
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の足場技術市場規模が2028年までに21億ドルに達すると予測しています。2021年から2028年までに年平均8.4%成長する見通しです。本市場調査資料では、足場技術の世界市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、種類別(ヒドロゲル、高分子足場、表面マイクロパターン型マイクロプレート、ナノファイバーベース足場)分析、用途別(幹細胞治療&再生医療&組織エンジニアリング、創薬、その他)分析、疾患別(整形外科&筋骨格系&脊椎、癌、皮膚&外皮、歯科、心臓病&血管)分析、最終用途別(バイオテクノロジー&製薬産業、研究室&研究機関、病院&診断センター、その他)分析、地域別分析、競争状況など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界の足場技術市場規模:種類別(ヒドロゲル、高分子足場、表面マイクロパターン型マイクロプレート、ナノファイバーベース足場)
・世界の足場技術市場規模:用途別(幹細胞治療&再生医療&組織エンジニアリング、創薬、その他)
・世界の足場技術市場規模:疾患別(整形外科&筋骨格系&脊椎、癌、皮膚&外皮、歯科、心臓病&血管)
・世界の足場技術市場規模:最終用途別(バイオテクノロジー&製薬産業、研究室&研究機関、病院&診断センター、その他)
・世界の足場技術市場規模:地域別
・競争状況
【レポートの概要】

Table of Contents

Chapter 1 Scaffold Technology: Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.1.3 Secondary sources:
1.1.4 Third party perspective:
1.1.5 Primary research:
1.2 Data Analysis
1.3 Market Formulation & Validation
1.4 Region Wise Market Calculation & Scope
1.4.1 Market scope: By application
1.4.2 Region wise market: Base estimates
1.4.3 Global market: CAGR calculation
1.4.4 Region based segment share calculation
Chapter 2 Scaffold Technology Market: Executive Summary
2.1 Market Summary, 2020
Chapter 3 Scaffold Technology: Market Variables, Trends, & Scope
3.1 Scaffold technology Market: Segment Outlook, 2017 – 2028
3.1.1 Market driver analysis
3.1.1.1 Increasing demand for 3D cellular models in translational research
3.1.1.2 Increasing demand for body reconstruction procedures and tissue engineering
3.1.1.3 Advancements in scaffold technology
3.1.2 Market restraint analysis
3.1.2.1 Introduction of scaffold-free technology for 3D cell culture
3.1.2.2 Lack of consistency in generated results
3.2 Penetration & Growth Prospect Mapping for Type, 2020
3.3 Scaffold Technology Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Scaffold Technology Market: Type Business Analysis
4.1 Scaffold Technology Market: Type Movement Analysis, 2020 & 2028
4.2 Hydrogels
4.2.1 Global scaffold technology market for hydrogels, 2017 – 2028 (USD Million)
4.2.2 Hydrogels, by application
4.2.2.1 Wound healing
4.2.2.1.1 Global hydrogels market for wound healing, 2017 – 2028 (USD Million)
4.2.3.1 3D bioprinting
4.2.3.1.1 Global hydrogels market for 3D bioprinting, 2017 – 2028 (USD Million)
4.2.4.1 Immunomodulation
4.2.4.1.1 Global hydrogels market for immunomodulation, 2017 – 2028 (USD Million)
4.3 Polymeric Scaffolds
4.3.1 Global scaffold technology market for polymeric scaffolds, 2017 – 2028 (USD Million)
4.4 Micropatterned Surface Microplates
4.4.1 Global scaffold technology market for micropatterned surface microplates, 2017 – 2028 (USD Million)
4.5 Nanofiber-based Scaffolds
4.5.1 Global scaffold technology market for nanofiber-based scaffolds, 2017 – 2028 (USD Million)
Chapter 5 Scaffold Technology Market: Application Business Analysis
5.1 Scaffold Technology Market: Application Movement Analysis, 2020 & 2028
5.2 Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
5.2.1 Cell encapsulations for regenerative medicine
5.2.2 Global scaffold technology market for stem cell therapy, regenerative medicine, & tissue engineering, 2017 – 2028 (USD Million)
5.3 Drug Discovery
5.3.1 Global scaffold technology market for drug discovery, 2017 – 2028 (USD Million)
5.4 Others
5.4.1 Global scaffold technology market for others, 2017 – 2028 (USD Million)
Chapter 6 Scaffold Technology Market: Disease Type Business Analysis
6.1 Scaffold Technology Market: Disease Type Movement Analysis, 2020 & 2028
6.2 Orthopedics, Musculoskeletal, & Spine
6.2.1 Global scaffold technology market for orthopedics, musculoskeletal, & spine, 2017 – 2028 (USD Million)
6.3 Cancer
6.3.1 Analysis of extracellular matrix (ECM) scaffolds and nanotechnology-based strategies for cancer diagnosis and prognosis
6.3.2 Global scaffold technology market for cancer, 2017 – 2028 (USD Million)
6.4 Skin & Integumentary
6.4.1 Global scaffold technology market for skin & integumentary, 2017 – 2028 (USD Million)
6.5 Dental
6.5.1 Strategies for developing new smart tissue engineering scaffolds for dentine‐pulp complex regeneration
6.5.2 Global scaffold technology market for dental, 2017 – 2028 (USD Million)
6.6 Cardiology & Vascular
6.6.1 Global scaffold technology market for cardiology & vascular, 2017 – 2028 (USD Million)
6.7 Neurology
6.7.1 Global scaffold technology market for neurology, 2017 – 2028 (USD Million)
6.8 Urology
6.8.1 Global scaffold technology market for urology, 2017 – 2028 (USD Million)
6.9 Gastrointestinal Disorders (GI) & Gynecology
6.9.1 Global scaffold technology market for GI& gynecology, 2017 – 2028 (USD Million)
6.10 Others
6.10.1 Global scaffold technology market for other disease types, 2017 – 2028 (USD Million)
Chapter 7 Scaffold Technology Market: End-use Business Analysis
7.1 Scaffold Technology Market: End-use Movement Analysis, 2020 & 2028
7.2 Biotechnology and Pharmaceutical Industries
7.2.1 Global scaffold technology market for biotechnology and pharmaceutical industries, 2017 – 2028 (USD Million)
7.3 Research Laboratories and Institutes
7.3.1 Global scaffold technology market for research laboratories and institutes, 2017 – 2028 (USD Million)
7.4 Hospitals and Diagnostic Centers
7.4.1 Global scaffold technology market for hospitals and diagnostic centers, 2017 – 2028 (USD Million)
7.5 Others
7.5.1 Global scaffold technology market for others, 2017 – 2028 (USD Million)
Chapter 8 Scaffold Technology Market: Regional Business Analysis
8.1 Scaffold Technology Market: Regional Movement Analysis, 2020 & 2028
8.2 North America
8.2.1 North America scaffold technology market, 2017 – 2028 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. scaffold technology market, 2017 – 2028 (USD Million)
8.2.3 Canada
8.2.3.1 Canada scaffold technology market, 2017 – 2028 (USD Million)
8.3 Europe
8.3.1 Europe scaffold technology market, 2017 – 2028 (USD Million)
8.3.2 Germany
8.3.2.1 Germany scaffold technology market, 2017 – 2028 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. scaffold technology market, 2017 – 2028 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific scaffold technology market, 2017 – 2028 (USD Million)
8.4.2 Japan
8.4.2.1 Japan scaffold technology market, 2017 – 2028 (USD Million)
8.4.3 China
8.4.3.1 China scaffold technology market, 2017 – 2028 (USD Million)
8.5 Latin America
8.5.1 Latin America scaffold technology market, 2017 – 2028 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil scaffold technology market, 2017 – 2028 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 MEA scaffold technology market, 2017 – 2028 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa scaffold technology market, 2017 – 2028 (USD Million)
Chapter 9 Scaffold Technology Market: Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Merck KGaA
9.3.1.1 Company overview
9.3.1.2 Sigma-Aldrich, Inc.
9.3.1.2.1 Company overview
9.3.1.3 Merck Millipore
9.3.1.3.1 Company overview
9.3.1.4 Financial performance
9.3.1.5 Product benchmarking
9.3.1.6 Strategic initiatives
9.3.2 Thermo Fisher Scientific, Inc.
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Becton, Dickinson And Company
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.4 3D Biotek LLC
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Molecular Matrix, Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 REPROCELL, Inc.
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Xanofi
9.3.7.1 Company overview
9.3.7.2 Product benchmarking
9.3.7.3 Strategic initiatives
9.3.8 Tecan Trading AG
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Matricel GmbH
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Pelobiotech
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.11 Corning Incorporated
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 Akron Biotech
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 4titude
9.3.13.1 Company overview
9.3.13.2 Financial performance
9.3.13.3 Product benchmarking
9.3.14 3D Biomatrix
9.3.14.1 Company overview
9.3.14.2 Product benchmarking
9.3.15 Nanofiber Solutions
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 NuVasive, Inc.
9.3.16.1 Company overview
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 Avacta Life Sciences Limited
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
9.3.18 Medtronic
9.3.18.1 Company overview
9.3.18.2 Financial performance
9.3.18.3 Product benchmarking
9.3.18.4 Strategic initiatives
9.3.19 Allergan
9.3.19.1 Company overview
9.3.19.2 LifeCell Corporation
9.3.19.2.1 Company overview
9.3.19.3 Financial performance
9.3.19.4 Product benchmarking
9.3.19.5 Strategic initiatives
9.3.20 Vericel Corporation
9.3.20.1 Company overview
9.3.20.2 Financial performance
9.3.20.3 Product benchmarking
9.3.20.4 Strategic initiatives

【レポートの目次】

Table of Contents

Chapter 1 Scaffold Technology: Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.1.3 Secondary sources:
1.1.4 Third party perspective:
1.1.5 Primary research:
1.2 Data Analysis
1.3 Market Formulation & Validation
1.4 Region Wise Market Calculation & Scope
1.4.1 Market scope: By application
1.4.2 Region wise market: Base estimates
1.4.3 Global market: CAGR calculation
1.4.4 Region based segment share calculation
Chapter 2 Scaffold Technology Market: Executive Summary
2.1 Market Summary, 2020
Chapter 3 Scaffold Technology: Market Variables, Trends, & Scope
3.1 Scaffold technology Market: Segment Outlook, 2017 – 2028
3.1.1 Market driver analysis
3.1.1.1 Increasing demand for 3D cellular models in translational research
3.1.1.2 Increasing demand for body reconstruction procedures and tissue engineering
3.1.1.3 Advancements in scaffold technology
3.1.2 Market restraint analysis
3.1.2.1 Introduction of scaffold-free technology for 3D cell culture
3.1.2.2 Lack of consistency in generated results
3.2 Penetration & Growth Prospect Mapping for Type, 2020
3.3 Scaffold Technology Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Scaffold Technology Market: Type Business Analysis
4.1 Scaffold Technology Market: Type Movement Analysis, 2020 & 2028
4.2 Hydrogels
4.2.1 Global scaffold technology market for hydrogels, 2017 – 2028 (USD Million)
4.2.2 Hydrogels, by application
4.2.2.1 Wound healing
4.2.2.1.1 Global hydrogels market for wound healing, 2017 – 2028 (USD Million)
4.2.3.1 3D bioprinting
4.2.3.1.1 Global hydrogels market for 3D bioprinting, 2017 – 2028 (USD Million)
4.2.4.1 Immunomodulation
4.2.4.1.1 Global hydrogels market for immunomodulation, 2017 – 2028 (USD Million)
4.3 Polymeric Scaffolds
4.3.1 Global scaffold technology market for polymeric scaffolds, 2017 – 2028 (USD Million)
4.4 Micropatterned Surface Microplates
4.4.1 Global scaffold technology market for micropatterned surface microplates, 2017 – 2028 (USD Million)
4.5 Nanofiber-based Scaffolds
4.5.1 Global scaffold technology market for nanofiber-based scaffolds, 2017 – 2028 (USD Million)
Chapter 5 Scaffold Technology Market: Application Business Analysis
5.1 Scaffold Technology Market: Application Movement Analysis, 2020 & 2028
5.2 Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
5.2.1 Cell encapsulations for regenerative medicine
5.2.2 Global scaffold technology market for stem cell therapy, regenerative medicine, & tissue engineering, 2017 – 2028 (USD Million)
5.3 Drug Discovery
5.3.1 Global scaffold technology market for drug discovery, 2017 – 2028 (USD Million)
5.4 Others
5.4.1 Global scaffold technology market for others, 2017 – 2028 (USD Million)
Chapter 6 Scaffold Technology Market: Disease Type Business Analysis
6.1 Scaffold Technology Market: Disease Type Movement Analysis, 2020 & 2028
6.2 Orthopedics, Musculoskeletal, & Spine
6.2.1 Global scaffold technology market for orthopedics, musculoskeletal, & spine, 2017 – 2028 (USD Million)
6.3 Cancer
6.3.1 Analysis of extracellular matrix (ECM) scaffolds and nanotechnology-based strategies for cancer diagnosis and prognosis
6.3.2 Global scaffold technology market for cancer, 2017 – 2028 (USD Million)
6.4 Skin & Integumentary
6.4.1 Global scaffold technology market for skin & integumentary, 2017 – 2028 (USD Million)
6.5 Dental
6.5.1 Strategies for developing new smart tissue engineering scaffolds for dentine‐pulp complex regeneration
6.5.2 Global scaffold technology market for dental, 2017 – 2028 (USD Million)
6.6 Cardiology & Vascular
6.6.1 Global scaffold technology market for cardiology & vascular, 2017 – 2028 (USD Million)
6.7 Neurology
6.7.1 Global scaffold technology market for neurology, 2017 – 2028 (USD Million)
6.8 Urology
6.8.1 Global scaffold technology market for urology, 2017 – 2028 (USD Million)
6.9 Gastrointestinal Disorders (GI) & Gynecology
6.9.1 Global scaffold technology market for GI& gynecology, 2017 – 2028 (USD Million)
6.10 Others
6.10.1 Global scaffold technology market for other disease types, 2017 – 2028 (USD Million)
Chapter 7 Scaffold Technology Market: End-use Business Analysis
7.1 Scaffold Technology Market: End-use Movement Analysis, 2020 & 2028
7.2 Biotechnology and Pharmaceutical Industries
7.2.1 Global scaffold technology market for biotechnology and pharmaceutical industries, 2017 – 2028 (USD Million)
7.3 Research Laboratories and Institutes
7.3.1 Global scaffold technology market for research laboratories and institutes, 2017 – 2028 (USD Million)
7.4 Hospitals and Diagnostic Centers
7.4.1 Global scaffold technology market for hospitals and diagnostic centers, 2017 – 2028 (USD Million)
7.5 Others
7.5.1 Global scaffold technology market for others, 2017 – 2028 (USD Million)
Chapter 8 Scaffold Technology Market: Regional Business Analysis
8.1 Scaffold Technology Market: Regional Movement Analysis, 2020 & 2028
8.2 North America
8.2.1 North America scaffold technology market, 2017 – 2028 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. scaffold technology market, 2017 – 2028 (USD Million)
8.2.3 Canada
8.2.3.1 Canada scaffold technology market, 2017 – 2028 (USD Million)
8.3 Europe
8.3.1 Europe scaffold technology market, 2017 – 2028 (USD Million)
8.3.2 Germany
8.3.2.1 Germany scaffold technology market, 2017 – 2028 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. scaffold technology market, 2017 – 2028 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific scaffold technology market, 2017 – 2028 (USD Million)
8.4.2 Japan
8.4.2.1 Japan scaffold technology market, 2017 – 2028 (USD Million)
8.4.3 China
8.4.3.1 China scaffold technology market, 2017 – 2028 (USD Million)
8.5 Latin America
8.5.1 Latin America scaffold technology market, 2017 – 2028 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil scaffold technology market, 2017 – 2028 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 MEA scaffold technology market, 2017 – 2028 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa scaffold technology market, 2017 – 2028 (USD Million)
Chapter 9 Scaffold Technology Market: Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Merck KGaA
9.3.1.1 Company overview
9.3.1.2 Sigma-Aldrich, Inc.
9.3.1.2.1 Company overview
9.3.1.3 Merck Millipore
9.3.1.3.1 Company overview
9.3.1.4 Financial performance
9.3.1.5 Product benchmarking
9.3.1.6 Strategic initiatives
9.3.2 Thermo Fisher Scientific, Inc.
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Becton, Dickinson And Company
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.4 3D Biotek LLC
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Molecular Matrix, Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 REPROCELL, Inc.
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Xanofi
9.3.7.1 Company overview
9.3.7.2 Product benchmarking
9.3.7.3 Strategic initiatives
9.3.8 Tecan Trading AG
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Matricel GmbH
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Pelobiotech
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.11 Corning Incorporated
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 Akron Biotech
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 4titude
9.3.13.1 Company overview
9.3.13.2 Financial performance
9.3.13.3 Product benchmarking
9.3.14 3D Biomatrix
9.3.14.1 Company overview
9.3.14.2 Product benchmarking
9.3.15 Nanofiber Solutions
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 NuVasive, Inc.
9.3.16.1 Company overview
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 Avacta Life Sciences Limited
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
9.3.18 Medtronic
9.3.18.1 Company overview
9.3.18.2 Financial performance
9.3.18.3 Product benchmarking
9.3.18.4 Strategic initiatives
9.3.19 Allergan
9.3.19.1 Company overview
9.3.19.2 LifeCell Corporation
9.3.19.2.1 Company overview
9.3.19.3 Financial performance
9.3.19.4 Product benchmarking
9.3.19.5 Strategic initiatives
9.3.20 Vericel Corporation
9.3.20.1 Company overview
9.3.20.2 Financial performance
9.3.20.3 Product benchmarking
9.3.20.4 Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 Comparative performance analysis of different 3D cell culture techniques
TABLE 3 Comparative performance analysis of commercially available scaffolds-based 3D culture systems
TABLE 4 Classification of the scaffold fabrication technologies
TABLE 5 Comparison of different drug loading strategies for chitosan-based hydrogels
TABLE 6 Comparison of commonly used non-functionalized bioinks
TABLE 7 List of some of the commercially available polymeric scaffold products
TABLE 8 Hydrogels used for drug delivery
TABLE 9 Bioactive components of ECM scaffolds that play a role in constructive tissue remodeling outcomes
TABLE 10 ECM-derived molecules in cancer diagnosis
TABLE 11 Biomaterials‐based scaffolds for regeneration of the dentin‐pulp complex
TABLE 12 Scaffolds for neurology
TABLE 13 Scaffolds used as tubular urethral substitutes
TABLE 14 Preclinical and human studies evaluating the use of ECM bioscaffolds to repair GI tissue
TABLE 15 Biomaterials used for corneal bioengineering
TABLE 16 North America scaffold technology market estimates & forecasts, by type, 2017-2028 (USD Million)
TABLE 17 North America hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 18 North America scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 19 North America scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 20 North America scaffold technology market estimates & forecasts, by enduse, 2017 - 2028 (USD Million)
TABLE 21 U.S. scaffold technology market estimates & forecasts, by type, 2017-2028 (USD Million)
TABLE 22 U.S. hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 23 U.S. scaffold technology market estimates & forecasts, by application, 2017-2028(USD Million)
TABLE 24 U.S. scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 25 U.S. scaffold technology market estimates & forecasts, by enduse, 2017 - 2028 (USD Million)
TABLE 26 Canada scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 27 Canada hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 28 Canada scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 29 Canada scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 30 Canada scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 31 Europe scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 32 Europe hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 33 Europe scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 34 Europe scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 35 Europe scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 36 U.K. scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 37 U.K. hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 38 U.K. scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 39 U.K. scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 40 U.K. scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 41 Germany scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 42 Germany hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 43 Germany scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 44 Germany scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 45 Germany scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 46 Asia Pacific scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 47 Asia Pacific hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 48 Asia Pacific scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 49 Asia Pacific scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 50 Asia Pacific scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 51 Japan scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 52 Japan hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 53 Japan scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 54 Japan scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 55 Japan scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 56 China scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 57 China hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 58 China scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 59 China scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 60 China scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 61 Latin America scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 62 Latin America hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 63 Latin America scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 64 Latin America scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 65 Latin America scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 66 Brazil scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 67 Brazil hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 68 Brazil scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 69 Brazil scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 70 Brazil scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 71 MEA scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 72 MEA hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 73 MEA scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 74 MEA scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 75 MEA scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 76 South Africa scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
TABLE 77 South Africa hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 78 South Africa scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 79 South Africa scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
TABLE 80 South Africa scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)

List of Figures

FIG. 1 Market summary (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market segmentation & scope
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Classification of regenerative medicine on the basis of usage of scaffolds
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Challenges associated with the consistency of implications of scaffold technology
FIG. 14 Penetration & growth prospect mapping for type, 2020
FIG. 15 SWOT Analysis, by factor (political & legal, economic and technological)
FIG. 16 Porter’s Five Forces Analysis
FIG. 17 Scaffold technology market: Type outlook key takeaways
FIG. 18 Scaffold technology market: Type movement analysis
FIG. 19 Scaffold technology market for hydrogels, 2017 - 2028 (USD Million)
FIG. 20 Global polymeric hydrogels: Advantages and disadvantages
FIG. 21 Characteristics of chitosan-based hydrogels
FIG. 22 Application of chitosan-based hydrogel dressings
FIG. 23 Global hydrogels market for wound healing, 2017 - 2028 (USD Million)
FIG. 24 Characteristics of bioinks
FIG. 25 Global hydrogels market for 3D bioprinting, 2017 - 2028 (USD Million)
FIG. 26 Global hydrogels market for immunomodulation, 2017 - 2028 (USD Million)
FIG. 27 Global scaffold technology market for polymeric scaffolds, 2017 - 2028 (USD Million)
FIG. 28 Global scaffold technology market for micropatterned surface microplates, 2017 - 2028 (USD Million)
FIG. 29 Global scaffold technology market for nanofiber-based scaffolds, 2017 - 2028 (USD Million)
FIG. 30 Scaffold technology market: Application outlook key takeaways
FIG. 31 Scaffold technology market: Application movement analysis
FIG. 32 Global scaffold technology market for stem cell therapy, regenerative medicine, & tissue engineering, 2017 - 2028 (USD Million)
FIG. 33 Global scaffold technology market for drug discovery, 2017 - 2028 (USD Million)
FIG. 34 Global scaffold technology market for others, 2017 - 2028 (USD Million)
FIG. 35 Scaffold technology market: Disease type outlook key takeaways
FIG. 36 Scaffold technology market: Disease type movement analysis
FIG. 37 Global scaffold technology market for orthopedics, musculoskeletal, & spine, 2017 - 2028 (USD Million)
FIG. 38 Global scaffold technology market for cancer, 2017 - 2028 (USD Million)
FIG. 39 Global scaffold technology market for skin & integumentary, 2017 - 2028 (USD Million)
FIG. 40 Strategies for developing new smart tissue engineering scaffolds for dentine‐pulp complex regeneration
FIG. 41 Global scaffold technology market for dental, 2017 - 2028 (USD Million)
FIG. 42 Global scaffold technology market for cardiology & vascular, 2017 - 2028 (USD Million)
FIG. 43 Global scaffold technology market for neurology, 2017 - 2028 (USD Million)
FIG. 44 Applications of silk fibroin in urology
FIG. 45 Global scaffold technology market for urology, 2017 - 2028 (USD Million)
FIG. 46 Global scaffold technology market for GI & gynecology, 2017 - 2028 (USD Million)
FIG. 47 Global scaffold technology market for other disease types, 2017 - 2028 (USD Million)
FIG. 48 Scaffold technology market: End-use outlook key takeaways
FIG. 49 Scaffold technology market: End-use movement analysis
FIG. 50 Global scaffold technology market for biotechnology and pharmaceutical industries, 2017 - 2028 (USD Million)
FIG. 51 Global scaffold technology market for research laboratories and institutes, 2017 - 2028 (USD Million)
FIG. 52 Global scaffold technology market for hospitals and diagnostic centers, 2017 - 2028 (USD Million)
FIG. 53 Global scaffold technology market for others, 2017 - 2028 (USD Million)
FIG. 54 Regional marketplace: Key takeaway
FIG. 55 Scaffold technology regional outlook, 2020&2028
FIG. 56 North America scaffold technology market, 2017 - 2028 (USD Million)
FIG. 57 Number of transplants conducted in the U.S., 2018 by organs
FIG. 58 U.S. scaffold technology market, 2017 - 2028 (USD Million)
FIG. 59 Canada scaffold technology market, 2017 - 2028 (USD Million)
FIG. 60 Europe scaffold technology market, 2017 - 2028 (USD Million)
FIG. 61 Germany scaffold technology market, 2017 - 2028 (USD Million)
FIG. 62 U.K. scaffold technology market, 2017 - 2028 (USD Million)
FIG. 63 Asia Pacific scaffold technology market, 2017 - 2028 (USD Million)
FIG. 64 Japan scaffold technology market, 2017 - 2028 (USD Million)
FIG. 65 China scaffold technology market, 2017 - 2028 (USD Million)
FIG. 66 Latin America scaffold technology market, 2017 - 2028 (USD Million)
FIG. 67 Brazil scaffold technology market, 2017 - 2028 (USD Million)
FIG. 68 MEA scaffold technology market, 2017 - 2028 (USD Million)
FIG. 69 South Africa scaffold technology market, 2017 - 2028 (USD Million)
FIG. 70 Strategy framework
FIG. 71 Market participant categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の足場技術市場2021-2028:種類別、用途別(幹細胞、再生医療、創薬)、疾患別(癌、歯科、神経)、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆